Gene · 26040
Papers2,649
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,649
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unravelling the genetic basis of stuttering: GWAS meta-analysis highlights link with rare speech disorders. | medRxiv | 2026 | 42780237 | PubTator, text mining | PubMed |
| Development of a human iPSC and patient phenotyping resource for preclinical investigations of neurodevelopmental disorders. | Stem Cell Res | 2026 | 42612424 | PubTator, text mining | PubMed |
| Clinical Characteristics and Diagnosis of Myelodysplastic Syndrome Accompanied by Eosinophilia and Basophilia. | Clin Lab | 2026 | 42570659 | PubTator, text mining | PubMed |
| Longitudinal Molecular Characterization of a Rare TPM3::PDGFRB-Rearranged Myeloid/Lymphoid Neoplasm With Late CNL-Like Neutrophilic Evolution. | Eur J Haematol | 2026 | 42549531 | PubTator, text mining | PubMed |
| Long-read, whole-genome sequencing and chemotherapy response of two patient-derived organoids from a TP53- and KRAS-mutant ovarian carcinoma. | bioRxiv | 2026 | 42465424 | PubTator, text mining | PubMed |
| Cumulative incidence and prognostic factors for leukemic transformation in chronic myelomonocytic leukemia: a competing risk analysis. | BMC Cancer | 2026 | 42310629 | PubTator, text mining | PubMed |
| Schinzel-Giedion Syndrome in One of Dizygotic Twins: Confirmation of a De Novo SET Binding Protein 1 (SETBP1) Variant and Classic Multisystem Phenotype. | Cureus | 2026 | 42255817 | PubTator, text mining | PubMed |
| [Correlation between Peripheral Blood Immunological Markers and Gene Mutations in Myelodysplastic Syndrome]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42227435 | PubTator, text mining | PubMed |
| [Clinical Characteristics and Prognosis Analysis of MDS-RS Patients with Wild-Type SF3B1]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2026 | 42227434 | PubTator, text mining | PubMed |
| KATs in the MYST: A New Therapeutic Vulnerability for SETBP1-Mutated Myeloid Malignancies. | Blood Cancer Discov | 2026 | 42223213 | PubTator, text mining | PubMed |
| Is Unidentified Cytopenia Truly Unidentified? Or Are We Overlooking Clonality? | Medicina (Kaunas) | 2026 | 42195121 | PubTator, text mining | PubMed |
| Genomic characterisation of Chinese myeloid malignancies and its clinical correlates: insights from targeted next-generation sequencing. | Front Med (Lausanne) | 2026 | 42145737 | PubTator, text mining | PubMed |
| Specific anti-staphylococcal enterotoxin B IgE levels in intensive care COVID-19 patients. | Microb Pathog | 2026 | 42105931 | PubTator, text mining | PubMed |
| High tumor mutational burden and PIK3CA mutations correlate with poor Merkel cell carcinoma-specific survival. | JCI Insight | 2026 | 42018651 | PubTator, text mining | PubMed |
| Rare NUP98::SETBP1 fusion transcript in a refractory adult T-cell lymphoblastic lymphoma. | Am J Cancer Res | 2026 | 42004063 | PubTator, text mining | PubMed |
| CMML2AML: machine-learning discovery of co-mutations and specific single mutations predictive of blast transformation in chronic myelomonocytic leukemia. | Blood Cancer J | 2026 | 41965730 | PubTator, text mining | PubMed |
| One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol. | Blood Cancer J | 2026 | 41935083 | PubTator, text mining | PubMed |
| Genomic Landscape and Clinical Outcomes of Advanced Pediatric Myelodysplastic Syndromes. | Eur J Haematol | 2026 | 41934278 | PubTator, text mining | PubMed |
| From QI-disability to QID-12: creating a brief proxy-report measure of quality of life for children with intellectual disability. | Qual Life Res | 2026 | 41920472 | PubTator, text mining | PubMed |
| Single-cell transcriptional consequences of leukaemogenic SETBP1 mutations. | Br J Haematol | 2026 | 41881778 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/26040/papers